113 related articles for article (PubMed ID: 2822649)
1. The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci.
Andrew JH; Wale MC; Wale LJ; Greenwood D
J Antimicrob Chemother; 1987 Aug; 20(2):213-21. PubMed ID: 2822649
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
Hodinka RL; Jack-Wait K; Wannamaker N; Walden TP; Gilligan PH
Eur J Clin Microbiol; 1987 Feb; 6(1):100-3. PubMed ID: 3032607
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of LY146032 (daptomycin), a new peptolide.
Ehlert F; Neu HC
Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.
Jorgensen JH; Maher LA; Redding JS
Eur J Clin Microbiol; 1987 Feb; 6(1):91-6. PubMed ID: 3032612
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of LY146032 against staphylococci, streptococci, and enterococci.
Fass RJ; Helsel VL
Antimicrob Agents Chemother; 1986 Nov; 30(5):781-4. PubMed ID: 3026240
[TBL] [Abstract][Full Text] [Related]
7. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
[TBL] [Abstract][Full Text] [Related]
8. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
Benson CA; Beaudette F; Trenholm G
J Antimicrob Chemother; 1987 Aug; 20(2):191-6. PubMed ID: 2822645
[TBL] [Abstract][Full Text] [Related]
9. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children.
Kline MW; Mason EO; Kaplan SL; Lamberth LB; Johnson GS
J Antimicrob Chemother; 1987 Aug; 20(2):203-7. PubMed ID: 2822647
[TBL] [Abstract][Full Text] [Related]
10. Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Stratton CW; Liu C; Weeks LS
Antimicrob Agents Chemother; 1987 Aug; 31(8):1210-5. PubMed ID: 2820300
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of daptomycin against 297 staphylococcal isolates.
Digranes A; Benonisen E
Chemotherapy; 1990; 36(2):136-40. PubMed ID: 2155761
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
Coudron PE; Johnston JL; Archer GL
J Antimicrob Chemother; 1987 Oct; 20(4):505-11. PubMed ID: 2824426
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of LY146032 against anaerobic cocci.
Greenwood D; Palfreyman J
Eur J Clin Microbiol; 1987 Dec; 6(6):682-4. PubMed ID: 2831046
[TBL] [Abstract][Full Text] [Related]
14. LY146032: activity and resistance development in vitro.
Mouton RP; Mulders SL
J Antimicrob Chemother; 1987 Oct; 20(4):513-7. PubMed ID: 2824427
[TBL] [Abstract][Full Text] [Related]
15. In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide.
Liebowitz LD; Saunders J; Chalkley LJ; Koornhof HJ
Antimicrob Agents Chemother; 1988 Jan; 32(1):24-6. PubMed ID: 2831813
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
Verbist L
Antimicrob Agents Chemother; 1987 Feb; 31(2):340-2. PubMed ID: 3032099
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of LY146032 against gram-positive bacteria.
Silva M; Jacobus NV; Gorbach SL
Diagn Microbiol Infect Dis; 1988 Feb; 9(2):79-85. PubMed ID: 2838217
[TBL] [Abstract][Full Text] [Related]
18. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar.
Johnson AP; Mushtaq S; Warner M; Livermore DM
J Antimicrob Chemother; 2004 May; 53(5):860-2. PubMed ID: 15056637
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.
Greenwood D; Bidgood K; Turner M
J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]